These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2548716)

  • 21. An impaired neocortical Ih is associated with enhanced excitability and absence epilepsy.
    Strauss U; Kole MH; Bräuer AU; Pahnke J; Bajorat R; Rolfs A; Nitsch R; Deisz RA
    Eur J Neurosci; 2004 Jun; 19(11):3048-58. PubMed ID: 15182313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dopamine-dependent character of depressive-like behavior in WAG/Rij rats with genetic absence epilepsy].
    Sarkisova KIu; Kulikov MA; Midzianovskaia IS; Folomkina AA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2007; 57(1):91-102. PubMed ID: 17432322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMDA-NR1 and AMPA-GluR4 receptor subunit immunoreactivities in the absence epileptic WAG/Rij rat.
    van de Bovenkamp-Janssen MC; van der Kloet JC; van Luijtelaar G; Roubos EW
    Epilepsy Res; 2006 May; 69(2):119-28. PubMed ID: 16487682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography.
    Bouizar Z; Rostène WH; Milhaud G
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5125-8. PubMed ID: 3037535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.
    Ngomba RT; Biagioni F; Casciato S; Willems-van Bree E; Battaglia G; Bruno V; Nicoletti F; van Luijtelaar EL
    Neuropharmacology; 2005; 49 Suppl 1():89-103. PubMed ID: 16043198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and quantitative topographical distribution of salmon calcitonin-binding sites in rat kidney sections.
    Bouizar Z; Rostène WH; Moukhtar MS; Milhaud G
    FEBS Lett; 1986 Feb; 196(1):19-22. PubMed ID: 3002863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of renal calcitonin binding sites in mammalian and nonmammalian vertebrates.
    Bouizar Z; Khattab M; Taboulet J; Rostene W; Milhaud G; Treilhou-Lahille F; Moukhtar MS
    Gen Comp Endocrinol; 1989 Dec; 76(3):364-70. PubMed ID: 2555248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decrease in rat brain calcitonin binding sites and adenylyl-cyclase activity during ageing.
    Villa I; Guidobono F; Netti C; Pecile A; Giovanazzi S; Nicosia S
    Neuroreport; 1992 Jul; 3(7):601-4. PubMed ID: 1384767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors.
    Ikegame M; Ejiri S; Ozawa H
    Bone; 2004 Jul; 35(1):27-33. PubMed ID: 15207738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral characteristics of WAG/Rij rats susceptible and non-susceptible to audiogenic seizures.
    Sarkisova KY; Kulikov MA
    Behav Brain Res; 2006 Jan; 166(1):9-18. PubMed ID: 16183145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitonin and the kidney.
    Clifton-Bligh P; Robinson B; Poon T; Posen S
    Prog Biochem Pharmacol; 1980; 17():204-11. PubMed ID: 6259658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical and limbic excitability in rats with absence epilepsy.
    Tolmacheva EA; van Luijtelaar G; Chepurnov SA; Kaminskij Y; Mares P
    Epilepsy Res; 2004 Dec; 62(2-3):189-98. PubMed ID: 15579307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake and localization of 131I-labeled anti-calcitonin immunoglobulins in rat medullary thyroid carcinoma tissue.
    Gautvik KM; Svindahl K; Skretting A; Stenberg B; Myhre L; Ekeland A; Johannesen JV
    Cancer; 1982 Sep; 50(6):1107-14. PubMed ID: 7104951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantable calcitonin-secreting medullary carcinomas of the thyroid in the WAG-Rij rat.
    Boorman GA; Heersche JN; Hollander CF
    J Natl Cancer Inst; 1974 Oct; 53(4):1011-5. PubMed ID: 4427386
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumour calcitonin. Interaction with specific calcitonin receptors.
    Ham J; Ellison ML; Lumsden J
    Biochem J; 1980 Sep; 190(3):545-50. PubMed ID: 6258572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased binding of calcitonin to renal receptors in parathyroidectomized rats.
    Sraer J; Ardaillou R; Couette S
    Endocrinology; 1974 Aug; 95(2):632-7. PubMed ID: 4368809
    [No Abstract]   [Full Text] [Related]  

  • 37. [Heterogeneity of the mammalian thyroid gland and changes in the organ with age].
    Bykov VL
    Arkh Anat Gistol Embriol; 1979 Oct; 77(10):61-71. PubMed ID: 159679
    [No Abstract]   [Full Text] [Related]  

  • 38. Calcitonin and calcitonin gene-related peptide receptor binding sites in the rat central nervous system.
    Skofitsch G; Jacobowitz DM
    Ann N Y Acad Sci; 1992 Jun; 657():420-2. PubMed ID: 1322092
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcitonin receptors in the central nervous system of the rat.
    Rizzo AJ; Goltzman D
    Endocrinology; 1981 May; 108(5):1672-7. PubMed ID: 6260461
    [No Abstract]   [Full Text] [Related]  

  • 40. Distribution of calcitonin gene-related peptide receptors in the lung.
    Carstairs JR
    Eur J Pharmacol; 1987 Aug; 140(3):357-8. PubMed ID: 2443371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.